Marijuana associated with three-fold risk of death from hypertension

Marijuana use is associated with a three-fold risk of death from hypertension, according to new research.

If At First You Don’t Succeed, Try, Try Again!

As an attorney, I am always disappointed that the courts in this country – both at the state and federal level – have refused to get involved in the efforts to end marijuana prohibition and end the practice of treating responsible marijuana smokers as criminals. But that is the reality.

While the courts in this country have played a leading role in ending racial discrimination, in guaranteeing women the right to obtain a legal abortion, in protecting the rights of the LGBT community, and in many other areas involving the protection of personal freedom, they have consistently rejected attempts to declare state and federal anti-marijuana laws as unconstitutional.

But that does not mean that we should give up the fight in the courts, and rely only on voter initiatives and elected officials to fix this problem. As long as there are new legal arguments to be made, and fresh and hopefully more convincing facts to be argued, we must continue to engage the courts in this struggle for personal freedom.

Washington, et.al v. Sessions, et.al

One such legal challenge, Washington, et.al v. Sessions, et.al, was recently filed in US District Court in the Southern District of New York by lead attorney Michael Hiller, with NORML Legal Committee (NLC) attorneys David Holland and Joseph Bondy serving as co-counsel. The full complaint can be found here.

Individual plaintiffs in the suit were two young children, an American military veteran, and a retired professional football player, all of whom are medical marijuana patients; and a membership organization alleging their minority members have been discriminated against by the federal Controlled Substances Act.

Seeking to overturn the 2005 Supreme Court decision in Gonzales v. Raich, plaintiffs request a declaration that the CSA, as it pertains to the classification of Cannabis as a Schedule I drug, is unconstitutional, because it violates the Due Process Clause of the Fifth Amendment, an assortment of protections guaranteed by the First Amendment, and the fundamental Right to Travel. Further, plaintiffs seek a declaration that Congress, in enacting the CSA as it pertains to marijuana, violated the Commerce Clause, extending the breadth of legislative power well beyond the scope contemplated by Article I of the Constitution.

Named as defendants in the case are Attorney General Jeff Beauregard Sessions, Acting Administrator of the DEA Chuck Rosenberg, the Justice Department, the DEA and the Federal Government.

In their Complaint, plaintiffs allege that the federal government does not, and could not possibly, believe that Cannabis meets the definition of a Schedule I drug, which is reserved for the most dangerous of substances, such as heroin, LSD, and mescaline; and that classifying Cannabis as a “Schedule I drug,” is so irrational that it violates the U.S. Constitution.

 Among the other claims in the lawsuit are that the CSA: (i) was enacted and implemented in order to discriminate against African Americans and to suppress people’s First Amendment rights; and (ii) violates plaintiffs’ constitutional Right to Travel.

Joseph Bondy, a federal criminal defense attorney and legalization advocate, explained he felt it was important to “question the agenda of those who continue to push for enforcement of the CSA, given its unlawful and discriminatory impact and that so few in America support such an effort.” Co-counsel David Holland, a litigator and Executive Director of Empire State NORML, noted that “the efforts to criminalize Cannabis are relatively recent and were largely underwritten by racial and ethnic animus,” referring to recent findings that African Americans and other persons of color are four times as likely to be arrested under the CSA than white Americans, even though marijuana is used equally by people of color and Caucasians.

Perhaps the federal courts will surprise us at long last and finally take a critical look at marijuana prohibition, and find the courage to declare the CSA to be unconstitutional. That would be an enormous step forward in ending marijuana prohibition altogether. But regardless of the outcome of this particular suit, it is encouraging to see the criminal defense bar continue to push the legal envelope, and to advance the best and latest legal and factual arguments. At some point, the courts will have no choice but to strike downC1_8734_r_x prohibition as a violation of our personal freedom.

 

 

Colorado: Tax Revenue From The Legal Cannabis Industry Surpasses Half-Billion Dollars

Marijuana ScienceRevenues from Colorado’s legal cannabis industry have surpassed over a half-billion dollars since retail sales began on January 1, 2014.

According to an analysis by VS Strategies, cannabis-related taxes and fees have yielded $506,143,635 in new state revenue over the past three and one-half years. (Local tax revenue was excluded from the analysis.) Much of the revenue raised has gone to fund school construction projects, school-drop out and substance abuse prevention programs, and grant funding.

The half-billion dollar total far exceeds initial projections. Tax revenue from legal cannabis sales in Oregon and Washington have also exceeded regulators’ initial expectations. In Nevada, where retail sales to adult became legal on July 1, retailers reported over 40,000 transactions in just the first weekend.

New Hampshire: Marijuana Decriminalization Measure Signed Into Law

thumbs_upRepublican Gov. Chris Sununu signed legislation today decriminalizing minor marijuana possession offenses.

House Bill 640, which takes effect in 60 days, eliminates criminal penalties for the possession of up to 3/4 of an ounce of cannabis and/or up to five grams of hashish for those age 18 or older. Under the new law, first time offenders will receive a civil violation punishable by a $100 fine.

Presently, first-time marijuana possession is punishable by up to one year in prison, a potential $2,000 fine, and a criminal record.

New Hampshire will soon join the chorus of states that recognize the baseline level of dignity for it’s citizens and tourists who choose to consume marijuana,” said Justin Strekal, NORML Political Director. “Soon, throughout New England, individuals will be able to freely travel without the threat of jail time for possession of marijuana.”

New Hampshire is the only New England state that presently treats minor possession offenses as a criminal offense.

Canada should continue with separate medical stream after cannabis is legalized for recreational use: Study

After cannabis is legalized, Canada should continue with a separate medical cannabis stream to keep patients safe, argues a new commentary.

Closing medical marijuana dispensaries increases crime, according to new study

Contrary to popular belief, medical marijuana dispensaries (MMDs) reduce crime in their immediate areas, suggests a new report.

Legal cannabis laws impact teen use

A new study has found that adolescents living in medical marijuana states with a plethora of dispensaries are more likely to have tried new methods of cannabis use, such as edibles and vaping, at a younger age than those living in states with fewer dispensaries.

Rates of marijuana use, heavy use, and cannabis use disorder depend on where you live

Adult marijuana use rose significantly in states that passed loosely regulated medical marijuana laws (MMLs) according to a new study. The highest increases were reported among adults ages 26 and over. Little change was found in past-month marijuana use among adolescents or young adults between the ages 18 and 25.

Pennsylvania Governor to AG Sessions: Back Off!

In a recent letter to Attorney General Jeff Sessions, Pennsylvania Governor Tom Wolf wrote a pointed letter regarding the Department of Justice and it’s posturing to implement a crackdown of lawful state medical marijuana programs.

The full letter:

Dear Attorney General Sessions:

Last year, the Pennsylvania passed bipartisan legislation to legalize Medical Marijuana that I was proud to sign into law. The legislation was the result of conversations with Republicans and Democrats and fierce advocacy from families of children who were stricken with terrible illness that could be helped by Medical Marijuana.

We talked to kids who suffer dozens of seizures in a given day. We met veterans who have seen absolute terror and seek relief from the effects of their post-traumatic stress. We approached the responsibility of providing relief to the people of Pennsylvania very thoughtfully.

Since I signed the legislation, we have taken very careful and deliberate steps to implement the law so that those who are suffering can get relief while ensuring that the state is a responsible steward of the program.

Given the bipartisan and medical consensus for Medical Marijuana in Pennsylvania and many other states, I am disturbed to know that you are actively pursuing a change in federal law to go after medical marijuana suppliers.

We do not need the federal government getting in the way of Pennsylvania’s right to deliver them relief through our new medical marijuana program.

Your action to undo the protections of the Rohrabacher-Farr amendment, which prevents the use federal funds to disrupt states’ efforts to implement “their own State laws that authorize the use, distribution, possession or cultivation of medical marijuana” is misguided.

If you seek to further disrupt our ability to establish a legal way to deliver relief of medical marijuana to our citizens, I will ask the Attorney General of Pennsylvania to take legal action to protect our residents and state sovereignty.

Sincerely,

Governor Tom Wolf

Attorney General Jeff Sessions Photo by Gage Skidmore

Attorney General Jeff Sessions
Photo by Gage Skidmore

This comes in response to a recently revealed private letter that Jeff Sessions sent to Congressional leadership requesting that the DOJ be permitted to target and prosecute state-licensed medical cannabis facilities, currently prohibited by a spending rider known as the Rohrabacher-Blumenauer amendment.

“I believe it would be unwise for Congress to restrict the discretion of the Department to fund particular prosecutions, particularly in the midst of an historic drug epidemic and potentially long-term uptick in violent crime,” Sessions wrote, “The Department must be in a position to use all laws available to combat the transnational drug organizations and dangerous drug traffickers who threaten American lives.”

Jeff Sessions actually seems to believe that lawful medical marijuana patients, i.e. sick people, are causing the violent crime and contributing to transnational drug trafficking.

Deputy Attorney General Rod Rosenstein was questioned about federal marijuana policy during a Senate Judiciary Committee hearing earlier this week and he brought up current DOJ policy and left the door wide open to a potential crackdown.

“Jim Cole tried to deal with it in that memorandum and at the moment that memorandum is still in effect. Maybe there will be changes to it in the future but we’re still operating under that policy which is an effort to balance the conflicting interests with regard to marijuana,” stated Rosenstein, “So I can assure you that is going to be a high priority for me as the U.S. Attorneys come on board to talk about how to deal with that challenge in the states that have legalized or decriminalized marijuana, whether it be for recreational or medical use…”

The Cole Memo, is a Justice Department memorandum, authored by US Deputy Attorney General James Cole in 2013 to US attorneys in all 50 states directs prosecutors not to interfere with state legalization efforts and those licensed to engage in the plant’s production and sale, provided that such persons do not engage in marijuana sales to minors or divert the product to states that have not legalized its use, among other guidelines.

But while the Justice Department contemplates its next move, Wolf and other state politicians are taking action. Recently, Washington Gov. Jay Inslee (D), Colorado Gov. John Hickenlooper (D), Oregon Gov. Kate Brown (D) and Alaska Gov. Bill Walker (I) issued a letter to the new U.S. Attorney General and to Secretary of Treasury Mnuchin calling on them to uphold the Obama Administration’s largely ‘hands off’ policies toward marijuana legalization, as outlined in the Cole Memo.

“Overhauling the Cole Memo is sure to produce unintended and harmful consequences,” the governors wrote. “Changes that hurt the regulated market would divert existing marijuana product into the black market and increase dangerous activity in both our states and our neighboring states.”

Click here to send a message to your member of Congress to urge them to force the Department of Justice to respect state marijuana laws and then visit http://norml.org/act to support other efforts in your state and federally.

PA resident? Click here to send a message to your state lawmakers to support the effort to decriminalize marijuana in the Keystone State.

Marijuana use among college students on rise following Oregon legalization, study finds

College students attending an Oregon university are using more marijuana now that the drug is legal for recreational use, but the increase is largely among students who also report recent heavy use of alcohol, a new study has found.

Why the marijuana and tobacco policy camps are on very different paths

New research looked at diverging trajectories of cannabis and tobacco policies in the US and attempts to explain some of the reasoning behind the different paths, while discussing possible implications.

Review Identifies 140 Controlled Clinical Trials Related to Cannabis

Marijuana researchScientists have conducted over 140 controlled clinical trials since 1975 assessing the safety and efficacy of whole-plant cannabis or specific cannabinoids, according to a new literature review published in the journal Critical Reviews in Plant Sciences.

A pair of German researchers identified 140 clinical trials involving an estimated 8,000 participants. Of these, the largest body of literature focused on the use of cannabis or cannabinoids in the treatment of chronic or neuropathic pain. Authors identified 35 controlled studies, involving 2,046 subjects, assessing the use of marijuana or cannabinoids in pain management. In January, the National Academy of Sciences acknowledged that “conclusive or substantial evidence” exists for cannabis’ efficacy in patients suffering from chronic pain.

Cannabinoids have also been well studied as anti-emetic agents and as appetite stimulants. Researchers identified 43 trials evaluating marijuana or its components for these purposes, involving total 2,498 patients. They also identified an additional 14 trials examining the role of cannabis or cannabis-derived extracts in the treatment of multiple sclerosis.

Researchers also identified several additional trials evaluating the use of cannabis or cannabinoids for Crohn’s disease, Tourette’s syndrome, Parkinson’s disease, glaucoma, epilepsy, and various other indications.

A 2014 study published in the Journal of the American Medical Association reported that new drugs typically gain FDA approval on the basis of one or two pivotal clinical trials.

Full text of the study, “Medicinal uses of marijuana and cannabinoids,” appears online here.

Low-dose THC can relieve stress; more does just the opposite

Low levels tetrahydrocannabinol, or THC, the main psychoactive compound in marijuana, does reduce stress, but in a highly dose-dependent manner, new research confirms.

Legalizing marijuana will harm health of youth in Canada, study shows

The Canadian federal government‘s bill C-45 to legalize marijuana in Canada will jeopardize the health of young people and Parliament should vote against it, argues a new article.

Las Vegas NORML Ramps up Advocacy Efforts

1294bbf7-8ed0-450d-9f98-5f7fd0090ae4With state lawmakers in Nevada quickly approaching their fast-tracked deadline of July 1st to implement the state’s new adult-use marijuana program, NORML is focused on ramping up our activism efforts in Las Vegas!

Over the past two months, we’ve been busy planning, attending legislative hearings, tabling at events, doing community outreach, volunteering at our local community garden, and more to get the word out about our new chapter, and post-legalization activism in Las Vegas.

So far during the 2017 legislative session, there have been several key pieces of legislation introduced. One of the most important bills that we’re currently pushing is Senator Tick Segerblom’s SB 329, which would safeguard many protections for marijuana patients and the legal marijuana industry. These protections include re-establishing patient grow rights, allowing medical marijuana research facilities, allowing marijuana establishments to be organized as a corporation, and adds PTSD as a qualifying condition for medical marijuana.

Another important piece of legislation that we’re watching closely is SB 236; if adopted by lawmakers, this legislation would permit social use marijuana clubs across Nevada. With the issue of social marijuana consumption quickly becoming a main issue for marijuana advocates in post-legalization states, Las Vegas NORML believes this legislation would be the first step in providing marijuana consumers with a safe and legally defined space to responsibly consume their legally purchased marijuana.

To learn more, join us for our next meeting on Tuesday, May 23rd where we’ll discuss the various pieces of marijuana-related legislation in Nevada! Get involved and invite your friends!

17159166_1914499645452277_4695175184675219897_o

Creating a Space for Marijuana Activism

We’re at a crucial time in the legislative session, so we need our members and supporters to speak-up for Nevada marijuana consumers by urging their representatives to support marijuana-related legislation. To help facilitate this, Las Vegas NORML has organized a postcard writing party! This will give everyone a chance to share their personal stories and reasons why they support marijuana legislation with their lawmakers.

We also have two guest speakers from Nevada’s marijuana industry that will be joining us: DB Labs and Sahara Wellness. DB Labs will be educating our members on marijuana testing in Nevada, and Sahara Wellness will be sharing their story of helping patients in the community. Plus we’ll have event sign-ups, membership packages, legislative updates, and even FREE SNACKS! Who can say no to that?

Be sure to RSVP using our Facebook Event Page, and invite all of your friends in Las Vegas!

For more information on Las Vegas NORML, please find us on Facebook, Twitter, Instagram, or email us at LasVegasNORMLchapter@gmail.com.

Login | Register

Copyright Top Nug © All Rights Reserved · Top Nug Theme by Ame

PIXSELL8 Pixel Count Remaining